AR
Fagron N.V.
ARSUF · OTC
$27.50 +0.00% (+$0.00)
Market Cap 1.73B €
P/E Ratio 19.06x
Div. Yield 1.69%
ROE 16.95%
Bulios Fair Price
$30.15
9.6% upside
Trenutna cena
$27.5
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica ARSUF trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
6/9Valuation
73 /100
Cheap P/FCF 15.35x
P/S 1.82x
P/B 3.14x
Growth
65 /100
Stable Rev. growth 11.65%
FCF growth 7.49%
Book val. growth 11.05%
Profitability
58 /100
Moderate Net margin 9.56%
Op. margin 15.36%
FCF margin 11.87%
Quality
68 /100
Excellent ROE 16.95%
ROA 7.32%
Asset turnover 0.77x
Debt
66 /100
Moderate Current ratio 2.11x
Int. coverage 4.47x
Net debt/EBITDA 1.70x
Stability
87 /100
Stable Rev. volatility 2.56%
EPS volatility 6.95%
Profitable years 6
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ARSUF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Rafael Padilla
Employees
4,134
Headquarters
Nazareth
Prihajajoči dogodki
18 FEB.
Earnings
Upcoming earnings report